Picture of Bioventix logo

BVXP Bioventix Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedSmall CapHigh Flyer

Annual cashflow statement for Bioventix, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
UAS
UAS
UAS
UAS
UAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5.665.867.26.737.67
Depreciation
Non-Cash Items1.311.21.11.611.86
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.11-1.25-0.752-2.14-2.12
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities5.925.887.686.347.56
Capital Expenditures-0.108-0.085-0.34-0.26-0.012
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.062-0.062-0.1810.0310.005
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.169-0.147-0.52-0.229-0.007
Financing Cash Flow Items-00-0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Cash from Financing Activities-4.93-6.18-5.62-7.69-7.92
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.82-0.4491.54-1.58-0.368

Or unlock with your email

Or unlock with your email